Diastat and Deafness bilateral - a phase IV clinical study of FDA data
We study 3,519 people who take Diastat or have Deafness bilateral. No report of Deafness bilateral is found in people who take Diastat.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Diastat?
Diastat has active ingredients of diazepam. eHealthMe is studying from 1,791 Diastat users for its effectiveness, alternative drugs and more.
What is Deafness Bilateral?
Deafness bilateral is found to be associated with 954 drugs and 655 conditions by eHealthMe.
Do you take Diastat and have Deafness bilateral?Check whether Deafness bilateral is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Deafness bilateral and when was it recovered:
Expand to all the drugs that have ingredients of diazepam:
Alternative drugs to, pros and cons of Diastat:
- Diastat (1,791 reports)
Deafness bilateral treatments and more:
- Deafness bilateral (1,728 reports)
COVID vaccines that are related to Deafness bilateral:
- Deafness bilateral in Moderna COVID Vaccine
- Deafness bilateral in Pfizer BioNTech Covid Vaccine
- Deafness bilateral in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Deafness bilateral:
All the conditions that are associated with Deafness bilateral:
How the study uses the data?
The study uses data from the FDA. It is based on diazepam (the active ingredients of Diastat) and Diastat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Baclofen and Meprobamate drug interaction - now
- Doxycycline Hyclate and Eosinophil Count Increased - 7 seconds ago
- Singulair and Asphyxia - 10 seconds ago
- Precose and Irritable Bowel Syndrome - 14 seconds ago
- Ketoprofen and Renal Tubular Necrosis - 15 seconds ago
- Lutein and Ozempic drug interaction - 16 seconds ago
- Hydrochlorothiazide and Pelvic Haematoma - 16 seconds ago
- Venofer and Heart Rate Irregular - 28 seconds ago
- Naproxen Sodium and Clonidine Hydrochloride drug interaction - 33 seconds ago
- Evista and Skin Hyperpigmentation - 44 seconds ago